Merck is currently trading at Rs. 2518.00, up by 17.90 points or 0.72% from its previous closing of Rs. 2500.10 on the BSE.
The scrip opened at Rs. 2549.00 and has touched a high and low of Rs. 2549.00 and Rs. 2516.70 respectively. So far 143 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2666.00 on 20-Jun-2018 and a 52 week low of Rs. 977.00 on 03-Jul-2017.
Last one week high and low of the scrip stood at Rs. 2,666.00 and Rs. 2,391.00 respectively. The current market cap of the company is Rs. 4150.01 crore.
The promoters holding in the company stood at 51.80%, while Institutions and Non-Institutions held 13.25% and 34.95% respectively.
Merck has entered into a business transfer agreement (BTA) with Merck Life Science (MLSPL) for the transfer of the Company's biopharma (BP), performance materials (PM) and life science (LS) businesses to MLSPL and/or its affiliates.
The Company has also entered into an agreement with MLSPL, Merck Specialities (MSPL) and Merck Performance Materials (MPMPL) for the said direct transfer of the BP and PM businesses to MSPL and MPMPL respectively.
MSPL and MPMPL are affiliates of MLSPL, all three entities being subsidiaries of the Company's ultimate holding company, Merck KGaA, Dannstadt, Germany.
Merck is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The company operates through two segments - Pharmaceuticals and Chemicals.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |